助力全球新药研发 关爱人类健康

       KCI BioTech and its wholly-owned subsidiary,KMQ BioTech are CROs specializing in preclinical efficacy and drugability evaluation for pharmaceutical R&D fields.

       The company owns two AAALAC-accredited laboratory animal facilities in Suzhou and Nantong, with a total area of more than 40,000 square meters, which can meet the needs of various types of preclinical research. The company has a full range of laboratory animal platforms including mice, hamsters, guinea pigs, rabbits, cats, dogs, pigs, ferrets and non-human primates, an in vivo pharmacodynamic evaluation platform with 400+ models, an anti-infective research and development service platform……

了解更多+

成立于

平米
占地面积

+
客户数量

专业人员
新闻正在更新,欢迎了解最新资讯
Company news Industry news
关闭